ELDN Eledon Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$2.49
· of 52w range
· above low
· to high
$1.3552w low
$4.6052w high
Market Cap (MRQ)
$201M
P/E
-4.8
EPS
$-0.52
your badges
52W Range
$1–$5
Analyst Rating
BUY
Price Target
$9
P/E
-4.8
ROE
-69.4%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
ELDN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$2.49
Market Cap (MRQ)
$201M
P/E
-4.8
EPS
$-0.52
ROE
-69.4%
52W Range
$1–$5
ELDN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Oct. 5, 2020 | 1-for-18 | Reverse |
| May 11, 2017 | 1-for-9 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2016-12-31 → 2016-12-31
EPS$-0.522021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ELDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -4.85Y avg ≈-2.4 | ≈-2.4 | · | · | |
| P/B (MRQ) | 6.15Y avg ≈0.7 | ≈0.7 | 2.1 | Overvalued | |
| Price / Cash Flow | -3.05Y avg ≈-1.7 | ≈-1.7 | · | · | |
| Price / Tangible Book | 2.35Y avg ≈1.8 | ≈1.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | ELDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -26.3%5Y avg ≈-37.3% | ≈-37.3% | -36.3% | Top tier | |
| ROE | -69.4%5Y avg ≈-56.0% | ≈-56.0% | -50.1% | Weak |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ELDN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 7.95Y avg ≈12.2 | ≈12.2 | 7.7 | In line | |
| Quick Ratio | 7.35Y avg ≈11.8 | ≈11.8 | 7.4 | In line |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
50.0%
Next Report
Nov 12, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 13, 2026 | $-0.27 | $-0.16 | -67.5% |
| March 31, 2026 | May 12, 2026 | $-0.33 | $-0.19 | -77.2% |
| Dec. 31, 2025 | $-0.10 | $-0.21 | 51.8% | |
| Sept. 30, 2025 | $-0.21 | $-0.26 | 17.6% | |
| June 30, 2025 | $-0.13 | $-0.23 | 44.6% | |
| March 31, 2025 | $-0.08 | $-0.31 | 74.1% | |
| Dec. 31, 2024 | $0.67 | $-0.32 | 306.5% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | |
| R&D Expense | $66M | $52M | $30M | $27M | $24M | $6M | $8M | $7M | $2M | $3M | $33M | $15M | |
| SG&A Expense | $17M | $19M | $13M | $13M | $13M | $10M | $6M | $7M | $11M | $2M | $13M | $9M | |
| Operating Expenses | $83M | $71M | $43M | $88M | $37M | $18M | $16M | $14M | $13M | $5M | $45M | $23M | |
| Operating Income | · | · | $-43M | $-88M | $-37M | $-18M | $-16M | $-14M | $-13M | $-5M | $-45M | $-23M | |
| Other Non-op | $4M | $4M | $3M | $462.0K | $7.0K | $79.0K | $40.0K | $-5.0K | $5.0K | $-527.0K | · | $166.0K | |
| Pretax Income | $-46M | $-36M | $-117M | $-88M | $-37M | $-23M | $-16M | $-14M | $-13M | $-6M | · | · | |
| Income Tax | $35.0K | $431.0K | $0 | $0 | $-2M | $-404.0K | · | · | · | $0 | $0 | $0 | |
| Net Income | $-46M | $-36M | $-117M | $-88M | $-35M | $-23M | $-16M | $-14M | $-13M | $-6M | $-45M | $-23M | |
| EPS (Basic) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · | |
| Shares (Basic) | 81,836,246 | 48,543,787 | 24,619,197 | 14,285,254 | 14,819,582 | · | · | · | · | · | · | · | |
| Shares (Diluted) | 81,836,246 | 48,543,787 | 24,619,197 | 14,285,254 | 14,819,582 | · | · | · | · | · | · | · | |
| EBITDA | · | · | · | $-88M | $-37M | $-18M | $-16M | · | $-13M | · | $-45M | $-23M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $23M | $21M | $5M | $56M | $85M | $114M | $9M | $13M | $17M | $1M | $24M | $105M | |
| Short-term Investments | $111M | $120M | $46M | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $2M | $4M | $5M | $3M | $4M | $1M | $1M | $1M | $2M | $33.0K | $3M | $2M | |
| Other Current Assets | $11.0K | $104.0K | $90.0K | $28.0K | $34.0K | $38.0K | $54.0K | $36.0K | $18.0K | $33.0K | · | · | |
| Current Assets | $136M | $144M | $56M | $60M | $88M | $116M | $10M | $14M | $19M | $1M | $67M | $108M | |
| PP&E (Net) | · | · | · | · | · | · | $5.0K | $14.0K | $25.0K | $31.0K | $489.0K | $33.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | $228.0K | $654.0K | $91.0K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | $130.0K | $165.0K | $58.0K | |
| Goodwill | · | · | $0 | $0 | $49M | $49M | · | $2M | $2M | · | · | · | |
| Other Non-current Assets | $322.0K | $363.0K | $186.0K | $150.0K | $400.0K | $383.0K | $639.0K | $869.0K | · | $15.0K | $45.0K | · | |
| Total Assets | $169M | $177M | $89M | $93M | $171M | $197M | $11M | $17M | $21M | $1M | $68M | $108M | |
| Accounts Payable | $4M | $6M | $967.0K | $2M | $2M | $1M | $329.0K | $689.0K | $418.0K | $338.0K | $1M | $765.0K | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | $113.0K | $5M | $3M | |
| Current Liabilities | $18M | $12M | $4M | $6M | $4M | $2M | $1M | $3M | · | $4M | $6M | $4M | |
| Capital Leases | $283.0K | $640.0K | $0 | $383.0K | $400.0K | · | $144.0K | · | · | · | · | · | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $4M | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | · | $88.0K | · | |
| Total Liabilities | $32M | $59M | $82M | $9M | $7M | $7M | $1M | $3M | $1M | $4M | $6M | $4M | |
| Common Stock | $75.0K | $60.0K | $24.0K | $14.0K | $14.0K | $15.0K | $1.0K | $9.0K | $7.0K | $1.0K | $23.0K | $22.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | $190M | |
| Retained Earnings | $-401M | $-356M | $-319M | $-203M | $-115M | $-80M | $-58M | $-42M | $-28M | $-14M | $-131M | $-86M | |
| AOCI | $24.0K | $26.0K | · | · | · | · | · | · | · | $-1.0K | $-55.0K | · | |
| Stockholders' Equity | $81M | $62M | $-48M | $24M | $164M | $191M | $9M | $14M | $19M | $-3M | $3M | $104M | |
| Liabilities + Equity | $169M | $177M | $89M | $93M | $171M | $197M | $11M | $17M | $21M | $1M | $68M | $108M | |
| Shares Outstanding | 75,430,033 | 59,789,275 | 24,213,130 | 13,776,788 | 14,306,788 | 15,160,397 | 720,408 | 9,422,143 | 7,110,414 | 394,306 | 22,597,144 | 22,382,340 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $5.0K | $9.0K | $11.0K | $22.0K | $35.0K | · | · | |
| Stock-based Comp | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| Deferred Tax | $5.0K | $431.0K | · | · | $-2M | $-404.0K | · | · | · | · | · | · | |
| Restructuring | · | · | · | · | $2M | $2M | · | · | · | · | · | · | |
| Operating Cash Flow | $-62M | $-47M | $-40M | $-28M | $-29M | $-15M | $-14M | $-12M | $-15M | $-5M | $-41M | $-21M | |
| CapEx | · | · | · | · | · | · | · | · | · | $9.0K | $565.0K | $25.0K | |
| Investing Cash Flow | $11M | $-70M | $-45M | · | · | $11M | · | · | $23M | · | · | · | |
| Stock Issued | · | · | · | · | · | $9M | $10M | $7M | $5M | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $9M | $10M | · | $5M | · | · | · | |
| Financing Cash Flow | $54M | $134M | $33M | · | $-449.0K | $110M | $10M | $8M | $8M | · | · | · | |
| Net Change in Cash | $2M | $16M | $-52M | $-28M | $-29M | $105M | $-4M | $-4M | $16M | $-2M | $-81M | $74M | |
| Taxes Paid | $28.0K | · | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | $-42M | $-21M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -26.3% | · | · | -66.8% | -18.8% | -21.9% | -114.5% | · | -118.8% | · | -51.3% | -33.3% | |
| ROE | -69.4% | · | · | -78.1% | -20.6% | -21.5% | -140.3% | · | -156.6% | · | -54.6% | -96.6% | |
| ROIC | · | · | · | -105.0% | -21.0% | -9.5% | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.4 | · | · | 9.2 | 20.1 | 46.6 | 7.5 | · | · | · | 10.9 | 25.3 | |
| Quick Ratio | 7.3 | · | · | 8.7 | 19.3 | 46.0 | 6.6 | · | · | · | 3.9 | 24.8 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.07 | · | · | $6.11 | $11.46 | $12.57 | $0.73 | · | $2.74 | · | $2.73 | $4.62 | |
| Cash Flow / Share | $-0.76 | · | $-1.61 | $-1.99 | · | · | · | · | · | · | · | · | |
| Cash / Share | $0.30 | · | · | $4.09 | $5.93 | $7.53 | $0.68 | · | $2.42 | · | $1.06 | $4.70 | |
| EPS (TTM) | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-46M | $-36M | $-117M | $-88M | $-35M | $-23M | $-16M | $-14M | $-13M | $-6M | $-45M | $-23M | |
| Market Cap | $114M | · | · | $31M | $63M | $233M | $135M | · | $520M | · | $31.92B | $53.45B | |
| P/E | -2.9 | -6.2 | -0.4 | -0.4 | -1.9 | · | · | · | · | · | · | · | |
| P/B | 1.4 | · | · | 0.4 | 0.4 | 1.2 | 14.3 | · | 26.7 | · | 517.2 | 516.4 | |
| P / Tangible Book | 1.4 | 3.9 | · | 1.3 | 0.5 | 1.6 | · | · | · | · | · | · | |
| P / Cash Flow | -1.8 | · | · | -1.1 | -2.2 | -15.3 | -9.8 | · | -34.8 | · | -774.1 | -2530.5 | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | -763.7 | -2527.5 | |
| Earnings Yield | -34.4% | -16.0% | -262.8% | -270.2% | -52.8% | · | · | · | · | · | · | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $18M | $17M | $17M | $15M | $20M | $14M | $18M | $17M | $10M | $7M | $7M | $8M | $7M | $8M | $7M | $7M | |
| SG&A Expense | $5M | $4M | $4M | $4M | $4M | $4M | $7M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Operating Expenses | $23M | $21M | $21M | $19M | $25M | $18M | $25M | $21M | $15M | $11M | $10M | $11M | $10M | $11M | $59M | $11M | |
| Operating Income | $-23M | $-21M | · | $-19M | $-25M | $-18M | · | $-21M | $-15M | $-11M | · | $-11M | $-10M | $-11M | · | $-11M | |
| Other Non-op | $862.0K | $1M | $540.0K | $1M | $1M | $1M | $1M | $1M | $869.0K | $574.0K | $712.0K | $849.0K | $775.0K | $338.0K | $304.0K | $127.0K | |
| Pretax Income | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-58M | $-10M | |
| Net Income | $-32M | $-39M | $-10M | $-17M | $-11M | $-6M | $-45M | $77M | $-45M | $-24M | $-30M | $-10M | $-66M | $-11M | $-58M | $-10M | |
| EPS (Basic) | $-0.27 | $-0.33 | $-0.10 | $-0.21 | $-0.13 | $-0.08 | $-0.14 | $1.05 | $-0.92 | $-0.65 | · | $-0.33 | $-2.74 | $-0.75 | $-4.09 | $-0.73 | |
| EPS (Diluted) | $-0.27 | $-0.33 | $-0.10 | $-0.21 | $-0.13 | $-0.08 | $1.19 | $-0.28 | $-0.92 | $-0.65 | · | $-0.33 | $-2.74 | $-0.75 | $-4.09 | $-0.73 | |
| Shares (Basic) | 113,631,565 | 112,424,211 | · | 77,156,068 | 77,156,068 | 77,126,763 | · | 51,945,920 | 42,278,411 | 29,989,400 | · | 29,974,400 | 24,006,549 | 14,285,905 | · | 14,265,905 | |
| Shares (Diluted) | 113,631,565 | 112,424,211 | · | 77,156,068 | 77,156,068 | 77,126,763 | · | 55,478,342 | 42,278,411 | 29,989,400 | · | 29,974,400 | 24,006,549 | 14,285,905 | · | 14,265,905 | |
| EBITDA | $-23M | $-21M | · | $-19M | $-25M | $-18M | · | $-21M | $-15M | $-11M | · | $-11M | $-10M | $-11M | · | $-11M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $6M | $23M | $4M | $6M | $8M | $21M | $7M | $26M | $6M | $5M | $4M | $41M | $46M | $56M | $66M | |
| Short-term Investments | $82M | $105M | $111M | $90M | $102M | $116M | $120M | $71M | $58M | $37M | $46M | $56M | $30M | · | $0 | · | |
| Prepaid Expense | $4M | $2M | $2M | $3M | $4M | $3M | $4M | $3M | $4M | $5M | $5M | $3M | $2M | $2M | $3M | $2M | |
| Other Current Assets | $382.0K | $9.0K | $11.0K | $14.0K | $10.0K | $55.0K | $104.0K | $442.0K | $157.0K | $54.0K | $90.0K | $90.0K | $238.0K | $47.0K | $28.0K | $57.0K | |
| Current Assets | $93M | $114M | $136M | $96M | $111M | $128M | $144M | $82M | $87M | $48M | $56M | $63M | $74M | $49M | $60M | $68M | |
| Goodwill | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $49M | |
| Other Non-current Assets | $172.0K | $177.0K | $322.0K | $476.0K | $346.0K | $354.0K | $363.0K | $210.0K | $255.0K | $185.0K | $186.0K | $233.0K | $224.0K | $369.0K | $150.0K | $155.0K | |
| Total Assets | $126M | $147M | $169M | $130M | $145M | $161M | $177M | $115M | $120M | $81M | $89M | $96M | $107M | $82M | $93M | $150M | |
| Accounts Payable | $3M | $7M | $4M | $5M | $6M | $3M | $6M | $6M | $2M | $2M | $967.0K | $465.0K | $2M | $3M | $2M | $4M | |
| Current Liabilities | $12M | $13M | $18M | $14M | $14M | $9M | $12M | $12M | $6M | $4M | $4M | $3M | $5M | $5M | $6M | $6M | |
| Capital Leases | $86.0K | $186.0K | $283.0K | $376.0K | $467.0K | $555.0K | $640.0K | $315.0K | $386.0K | $0 | · | $83.0K | $184.0K | $284.0K | $383.0K | $461.0K | |
| Deferred Tax | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Liabilities | $54M | $46M | $32M | $39M | $39M | $47M | $59M | $39M | $129M | $96M | $82M | $5M | $7M | $8M | $9M | $8M | |
| Common Stock | $81.0K | $76.0K | $75.0K | $60.0K | $60.0K | $60.0K | $60.0K | $41.0K | $39.0K | $25.0K | $24.0K | $24.0K | $23.0K | $14.0K | $14.0K | $14.0K | |
| Retained Earnings | $-472M | $-440M | $-401M | $-391M | $-373M | $-362M | $-356M | $-311M | $-388M | $-343M | $-319M | $-234M | $-223M | $-214M | $-203M | $-144M | |
| AOCI | $-114.0K | $-72.0K | $24.0K | $9.0K | $-48.0K | $-18.0K | $26.0K | $102.0K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $33M | $45M | $81M | $35M | $50M | $59M | $62M | $76M | $-9M | $-15M | $-48M | $91M | $100M | $75M | $84M | $141M | |
| Liabilities + Equity | $126M | $147M | $169M | $130M | $145M | $161M | $177M | $115M | $120M | $81M | $89M | $96M | $107M | $82M | $93M | $150M | |
| Shares Outstanding | 80,891,404 | 75,851,722 | 75,430,033 | 59,881,775 | 59,881,775 | 59,881,775 | 59,789,275 | 41,183,102 | 38,506,614 | 24,813,130 | 24,213,130 | 23,545,130 | 23,043,933 | 13,776,788 | 13,776,788 | 13,756,788 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-23M | $-23M | $-14M | $-14M | $-18M | $-16M | $-19M | $-12M | $-8M | $-9M | $-9M | $-12M | $-8M | $-10M | $-9M | $-5M | |
| Investing Cash Flow | $23M | $6M | $-20M | $12M | $15M | $4M | $-47M | $-13M | $-20M | $10M | $10M | $-25M | · | · | · | · | |
| Financing Cash Flow | · | · | $54M | $0 | $0 | $115.0K | $80M | $5M | $48M | $1.0K | $0 | $0 | · | · | · | · | |
| Net Change in Cash | $651.0K | $-17M | $19M | $-2M | $-3M | $-12M | $14M | $-19M | $20M | $1M | $945.0K | $-37M | $-6M | $-10M | $-9M | $-5M |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -23.3% | -25.3% | · | -14.3% | -8.5% | · | · | 73.1% | -39.5% | · | · | -8.4% | -7.3% | -8.8% | · | -6.4% | |
| ROE | -75.9% | -75.3% | · | -31.3% | -53.6% | · | · | 92.0% | -98.2% | · | · | -8.9% | -7.7% | -9.3% | · | -6.7% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.4 | · | 6.7 | 8.1 | 13.9 | · | 6.5 | 14.5 | 11.3 | · | 21.7 | 15.0 | 8.9 | · | 10.8 | |
| Quick Ratio | 7.5 | 8.3 | · | 6.5 | 7.8 | 13.6 | · | 6.3 | 13.9 | 10.1 | · | 20.6 | 14.6 | 8.5 | · | 10.5 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.41 | $0.59 | · | $0.59 | $0.84 | $0.98 | · | $1.85 | $-0.22 | $-0.59 | · | $3.88 | $4.34 | $5.43 | · | $10.26 | |
| Cash Flow / Share | · | $-0.20 | · | · | · | $-0.21 | · | · | · | $-0.29 | · | · | · | $-0.69 | · | · | |
| Cash / Share | $0.08 | $0.08 | · | $0.06 | $0.10 | $0.14 | · | $0.16 | $0.68 | $0.23 | · | $0.16 | $1.78 | $3.37 | · | $4.79 | |
| EPS (TTM) | $-0.91 | $-0.77 | · | $0.77 | $0.70 | $-0.09 | · | · | · | · | · | $-7.91 | $-8.31 | $-6.22 | · | $-2.67 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-99M | $-78M | · | $-80M | $15M | $-19M | · | $-22M | $-109M | $-129M | · | $-145M | $-145M | $-89M | · | $-38M | |
| Market Cap | $319M | $234M | · | $155M | $162M | $203M | · | $103M | $102M | $51M | · | $32M | $32M | $33M | · | $38M | |
| P/E | -4.3 | -4.0 | · | 3.4 | 3.9 | -37.7 | · | · | · | · | · | -0.2 | -0.2 | -0.4 | · | -1.0 | |
| P/B | 9.7 | 5.2 | · | 4.4 | 3.2 | 3.4 | · | 1.3 | -12.0 | -3.5 | · | 0.4 | 0.3 | 0.4 | · | 0.3 | |
| P / Tangible Book | 9.7 | 5.2 | · | 4.4 | 3.2 | 3.4 | · | 1.3 | · | · | · | 0.4 | 0.3 | 0.4 | · | 0.4 | |
| P / Cash Flow | · | -10.3 | · | · | · | -12.6 | · | · | · | -5.8 | · | · | · | -3.3 | · | · | |
| Earnings Yield | -23.1% | -25.0% | · | 29.7% | 25.8% | -2.6% | · | · | · | · | · | -577.4% | -606.6% | -263.6% | · | -96.7% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Net Income | $-46M | $-36M | $-117M | $-88M | $-35M |
| Diluted EPS | $-0.52 | $-0.66 | $-4.73 | $-6.16 | $-2.33 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 7.4 | · | · | 9.2 | 20.1 |
| Quick Ratio | 7.3 | · | · | 8.7 | 19.3 |
No data for this statement
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 172 filers · $193.6M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
172
Value held
$193.6M
New positions
54
Exited positions
9
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 54 (+11 vs prior Q) | 9 (-5 vs prior Q) | 61 (+26 vs prior Q) | 24 (+4 vs prior Q) | +5.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| BVF INC/IL | $24,795,531 | 6,293,282 | 12.81% | Shares |
| BlackRock, Inc. | $20,187,937 | 5,123,842 | 10.43% | Shares |
| Defilade Capital Management, L.P. | $13,889,832 | 3,525,338 | 7.18% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $13,463,859 | 3,417,223 | 6.96% | Shares |
| GOLDMAN SACHS GROUP INC | $9,890,613 | 2,510,308 | 5.11% | Shares |
| Ensign Peak Advisors, Inc | $8,278,823 | 2,101,224 | 4.28% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $7,710,867 | 1,956,601 | 3.98% | Shares |
| Catalio Capital Management, LP | $6,678,580 | 1,695,071 | 3.45% | Shares |
| STATE STREET CORP | $6,390,558 | 1,621,969 | 3.30% | Shares |
| Zimmer Partners, LP | $6,290,600 | 1,596,599 | 3.25% | Shares |
| VANGUARD GROUP INC | $6,099,926 | 4,039,686 | 3.15% | Shares |
| SPHERA FUNDS MANAGEMENT LTD. | $4,693,277 | 1,191,187 | 2.42% | Shares |
| AWM Investment Company, Inc. | $4,334,000 | 1,100,000 | 2.24% | Shares |
| UBS Group AG | $4,130,085 | 1,048,245 | 2.13% | Shares |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | $4,094,744 | 1,039,275 | 2.12% | Shares |
| MILLENNIUM MANAGEMENT LLC | $3,860,065 | 979,712 | 1.99% | Shares |
| BANK OF AMERICA CORP /DE/ | $3,479,402 | 883,097 | 1.80% | Shares |
| ADAR1 Capital Management, LLC | $2,552,379 | 647,812 | 1.32% | Shares |
| 22NW, LP | $2,507,274 | 636,364 | 1.30% | Shares |
| NORTHERN TRUST CORP | $2,428,612 | 616,399 | 1.25% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $2,289,251 | 581,028 | 1.18% | Shares |
| CM Management, LLC | $2,265,500 | 575,000 | 1.17% | Shares |
| Blue Owl Capital Holdings LP | $2,232,045 | 566,509 | 1.15% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $2,122,256 | 538,738 | 1.10% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $2,101,458 | 533,365 | 1.09% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,084,114 | 528,963 | 1.08% | Shares |
| MORGAN STANLEY | $1,911,262 | 485,092 | 0.99% | Shares |
| Triumph Capital Management | $1,195,565 | 303,443 | 0.62% | Shares |
| Brevan Howard Capital Management LP | $1,174,645 | 304,707 | 0.61% | Shares |
| CITADEL ADVISORS LLC | $1,100,836 | 279,400 | 0.57% | Put option |
| JANE STREET GROUP, LLC | $1,095,320 | 278,000 | 0.57% | Put option |
| BIT Capital GmbH | $1,048,040 | 266,000 | 0.54% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $993,794 | 252,232 | 0.51% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $978,302 | 248,300 | 0.51% | Put option |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $974,772 | 247,404 | 0.50% | Shares |
| CITADEL ADVISORS LLC | $850,934 | 215,973 | 0.44% | Shares |
| Nuveen, LLC | $823,842 | 209,097 | 0.43% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $791,546 | 200,900 | 0.41% | Shares |
| Bank of New York Mellon Corp | $657,690 | 166,927 | 0.34% | Shares |
| LPL Financial LLC | $440,078 | 111,695 | 0.23% | Shares |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $432,774 | 109,841 | 0.22% | Shares |
| Maven Securities LTD | $394,000 | 100,000 | 0.20% | Shares |
| RHUMBLINE ADVISERS | $349,112 | 88,609 | 0.18% | Shares |
| SIMPLEX TRADING, LLC | $349,072 | 88,597 | 0.18% | Shares |
| Prodigy Asset Management LLC | $341,610 | 86,703 | 0.18% | Shares |
| Daytona Street Capital LLC | $313,301 | 81,166 | 0.16% | Shares |
| DEUTSCHE BANK AG\ | $301,973 | 76,643 | 0.16% | Shares |
| WELLS FARGO & COMPANY/MN | $295,280 | 74,944 | 0.15% | Shares |
| Rockefeller Capital Management L.P. | $286,304 | 72,666 | 0.15% | Shares |
| Susquehanna Portfolio Strategies, LLC | $283,361 | 71,919 | 0.15% | Shares |
Activists & 5%+ owners 5 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| OrbiMed Israel BioFund GP Limited Partnership, OrbiMed Israel GP Ltd. ×9 filings | Jan. 5, 2021 | · | Initial filing | · | SEC |
| Novartis Bioventures Ltd., Novartis AG ×3 filings | April 5, 2019 | · | Initial filing | · | SEC |
| Apple Tree Partners II, L.P., Apple Tree Ventures II, L.P., Apple Tree Partners II - Annex, L.P., Apple Tree Ventures II - Annex, LLC, Apple Tree Partners IV, L.P., ATP III GP, Ltd., Seth L. Harrison ×4 filings | May 15, 2018 | · | Initial filing | · | SEC |
| Novartis Bioventures Ltd. (2), Novartis AG (2) | May 16, 2017 | · | Initial filing | · | SEC |
| Otic Pharma, Ltd. | Jan. 5, 2017 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 31 insiders · 9 officers · 20 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| David-Alexandre C Gros | Chief Executive Officer | July 31, 2026 F | 168,663 | 0 | 0 | $0 |
| Gregory J. Flesher | Chief Executive Officer | March 19, 2020 A | 156,918 | 0 | 0 | $0 |
| Paul Sean Little | Chief Financial Officer | Jan. 10, 2025 A | 10,000 | 0 | 0 | $0 |
| Lee Kalowski | Chief Financial Officer | Dec. 15, 2015 A | 40,953 | 0 | 0 | $0 |
| Steven Perrin | President | July 31, 2026 F | 81,215 | 0 | 0 | $0 |
| Bryan E. Smith | General Counsel, Corporate Sec | Jan. 10, 2025 A | · | 0 | 0 | $0 |
| Jon Kuwahara | Senior Vice President of Finance and Administration | Sept. 11, 2020 A | 5,974 | 0 | 0 | $0 |
| Karen Jean Ferrante | Head Res. & Dev. & Chief Med. | Dec. 15, 2015 A | · | 0 | 0 | $0 |
| Gerald E Quirk | General Counsel, Executive VP | Dec. 15, 2015 A | · | 0 | 0 | $0 |
| Allan Kirk | Director | Jan. 10, 2026 M | 3,430 | 0 | 0 | $0 |
| Jan Hillson | Director | Jan. 10, 2026 M | 3,430 | 0 | 0 | $0 |
| James A. Robinson Jr. | Director | Jan. 10, 2026 M | 3,430 | 0 | 0 | $0 |
| June Lee | Director | Jan. 10, 2026 M | 3,430 | 0 | 0 | $0 |
| John S. Mcbride | Director | Jan. 10, 2026 M | 3,430 | 0 | 0 | $0 |
| Keith Katkin | Director | Jan. 10, 2026 M | 8,575 | 0 | 0 | $0 |
| Walter C Ogier | Director | May 1, 2023 A | · | 0 | 0 | $0 |
| LYONS GARY A | Director | May 1, 2023 A | · | 0 | 0 | $0 |
| CHIMOVITS EREZ | Director | Jan. 14, 2020 S | 3,183,314 | 0 | 0 | $0 |
| Cheryl Cohen | Director | July 11, 2019 A | · | 0 | 0 | $0 |
| David A. Kessler | Director | June 15, 2016 A | · | 0 | 0 | $0 |
| Joseph A., Yanchik III | Director | June 15, 2016 A | · | 0 | 0 | $0 |
| Stephen Buckley Jr. | Director | June 15, 2016 A | 11,000 | 0 | 0 | $0 |
| Seth Loring Harrison | Director | June 15, 2016 A | 7,912,079 | 0 | 0 | $0 |
| BARBERICH TIMOTHY J | Director | June 15, 2016 A | 121,077 | 0 | 0 | $0 |
| Apple Tree Partners II - Annex, L.P. | Director | Sept. 22, 2014 C | 3,568,438 | 0 | 0 | $0 |
| APPLE TREE PARTNERS II LP | Director | Sept. 22, 2014 C | 4,218,641 | 0 | 0 | $0 |
| Logos Global Management LP | 10% owner | Oct. 30, 2020 P | 224,071 | 0 | 0 | $0 |
| Satter Muneer A | 10% owner | Sept. 22, 2014 C | 1,771,688 | 0 | 0 | $0 |
| Catherine C. Turkel | · | March 19, 2020 A | 88,662 | 0 | 0 | $0 |
| Jodie Pope Morrison | · | June 30, 2017 A | 57,566 | 0 | 0 | $0 |
| Christine Ocampo | · | May 24, 2017 A | 21,590 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 14 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0.05% | 261,650 SH | Sept. 11, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.02% | 83,093 SH | Aug. 19, 2026 | Daily |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0.02% | 17,733 SH | Oct. 2, 2026 | Daily |
| IWO · iShares Trust | 0.01% | 723,407 SH | Sept. 11, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 442,869 SH | Aug. 19, 2026 | Daily |
| RSSL · Global X Funds | 0.01% | 36,789 NS | July 31, 2026 | N-PORT |
| IWM · iShares Trust | 0.01% | 2,000,891 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.00% | 196,897 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 13,360 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 4,274 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 45,699 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 854,634 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 2,483,162 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 7,403 SH | Aug. 19, 2026 | Daily |
ELDN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 12 analysts
BUY
Median target
$8.00
+221.3%
4 33.3%
Strong Buy
7 58.3%
Buy
1 8.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
5 analysts · 2026-09-30Mean target $9.00 +261.4%
← Below all targets
Current price $2.49
Low$7.00
Mean$9.00
High$12.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| ELDN | $114M | -2.9 | · | · | -69.4% | · |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | · |
| CUE | $29M | -1.1 | 195.8% | -96.9% | -119.3% | · |
| CHRS | $172M | 1.0 | 59.8% | 398.4% | 185.8% | · |
| NKTX | $131M | -1.3 | · | · | -31.1% | · |
| CNTN | $112M | -2.7 | · | · | -18.0% | · |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026